Experimental study demonstrates scalable microfluidic formulation of ultradeformable liposomes for skin delivery, suggesting robust applications in pharmaceuticals and cosmeceuticals.
These findings highlight the potential of microfluidics as a robust and scalable technology for the industrial production of ultradeformable liposomes designed to enhance the dermal delivery of bioactive phytocomplex for both pharmaceutical and cosmeceutical applications.
No takes yet. Share an insight, caveat, or question.
Ciriolo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: